{"title":"Sally Smith Hughes","description":"\u003cp\u003eSally Smith Hughes offers insightful explorations into the world of biotechnology, blending scientific detail with compelling narrative. Her works illuminate the pioneering efforts behind major advancements in science, making complex topics accessible and engaging for readers intrigued by the stories behind innovation.\u003c\/p\u003e\n\n\u003cp\u003eFocused primarily on the history and development of biotech industries, Hughes delves into the intersection of science, business, and society. Her writing captures the challenges and triumphs that shape modern scientific progress, appealing to those fascinated by the evolution of science and nature.\u003c\/p\u003e","products":[{"product_id":"genentech-by-sally-smith-hughes-9780226359182","title":"Genentech","description":"\u003cdiv class=\"book-description\"\u003e\n\u003cp\u003eIn the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, marking the largest gain in stock market history at that time.\u003c\/p\u003e\n\n\u003cp\u003eComing at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech’s improbable creation, precarious youth, and ascent to immense prosperity.\u003c\/p\u003e\n\n\u003cp\u003eHughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech’s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests, university research, government regulation, venture capital, and commercial profits.\u003c\/p\u003e\n\n\u003cp\u003eIntegrating the scientific, the corporate, the contextual, and the personal, \u003ci\u003eGenentech\u003c\/i\u003e tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Unknown","offers":[{"title":"Default Title","offer_id":46854551175404,"sku":"9780226359182","price":66.99,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0705\/7784\/8556\/files\/bbe05d038c7d4be74ab1947b349c37c7.jpg?v=1759268638"},{"product_id":"genentech-the-beginnings-of-biotech-by-sally-smith-hughes-9780226045511","title":"Genentech – The Beginnings of Biotech","description":"\u003cdiv class=\"book-description\"\u003e\n\u003cp\u003eIn the autumn of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history.\u003c\/p\u003e\n\n\u003cp\u003eComing at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.\u003c\/p\u003e\n\n\u003cp\u003eDrawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech’s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science.\u003c\/p\u003e\n\n\u003cp\u003eBy placing Genentech’s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, \u003ci\u003eGenentech\u003c\/i\u003e tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Unknown","offers":[{"title":"Default Title","offer_id":47995456422124,"sku":"9780226045511","price":39.99,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0705\/7784\/8556\/files\/9780226045511-genentech-the-beginnings-of-biotech.jpg?v=1784895856"}],"url":"https:\/\/bookhero.pro\/collections\/sally-smith-hughes.oembed","provider":"Book Hero","version":"1.0","type":"link"}